About
Control Bionics Limited is an Australian medical technology company based in Cremorne, Victoria. Founded in 2005, it specializes in assistive communication technology systems aimed at helping individuals with speech and movement difficulties. The company operates internationally, including in North America, and focuses on developing innovative augmentative and alternative communication (AAC) devices. Their product lineup includes the NeuroNode Trilogy, a wireless wearable sensor system that detects bioelectric signals; the NeuroNode Duo, which enables access to technology through these signals; and the Eye-gaze Duo, combining eye-tracking technology with NeuroNode sensors. Other offerings include Cosmos Connect, a portable control device, and Uno Touch, a dedicated speech-generating device. These products support individuals with various neurological conditions, such as cerebral palsy, spinal cord injuries, and multiple sclerosis, enabling them to communicate and interact with their environment effectively. Control Bionics is committed to continuous innovation and has established strategic partnerships to expand its market presence, including an exclusive distribution agreement in the UK.
Technologies
Keywords
Company Information
-
Employees 25
-
Founded 2006
-
Annual Revenue $4017000
-
Total Funding $4523312
Location
11 Pearson St, Melbourne, Victoria, Australia, 3121
